NDC 51672-4063-01 - Fluorouracil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4063
- Requested NDC
- 51672-4063-01
- Package NDCs from labels
- 51672-4063-1, 51672-4063-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fluorouracil Topical Solution USP, 2% and 5% | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4063-1 | Fluorouracil | 10 mL in 1 BOTTLE | SOLUTION | 10 | 6 | |
| 51672-4063-1 | Fluorouracil | 1 in 1 CARTON | SOLUTION | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4063 | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 6 | Current NDC, Legacy NDC, 2 package rows | 20221014_1b2f6145-b338-42ed-88a7-f4da65c59164.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4063-1 | ML - Milliliter | 51672-4063 | a1683e15-d1e0-4721-b1ca-487b03c17c76 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Fluorouracil | ACTIVE INGREDIENT | U3P01618RT | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Fluorouracil | ACTIVE MOIETY | U3P01618RT | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| edetate disodium | INACTIVE INGREDIENT | 7FLD91C86K | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| hydroxypropyl cellulose | INACTIVE INGREDIENT | RFW2ET671P | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| tromethamine | INACTIVE INGREDIENT | 023C2WHX2V | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | FLUOROURACIL SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Avenova Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | NovaBay Pharmaceuticals, Inc. | cd17f037-5aa5-0ef8-e053-2a95a90a39cb | 2025-12-30 | Warnings | 6DC9Q167V3 |
| Equate Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Walmart, Inc. | deebaf7f-f20d-4d7f-e053-2a95a90a4b4f | 2025-12-30 | Warnings | 6DC9Q167V3 |
| CorneaCare Recover Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | CorneaCare Inc. | 1fd3a5ed-8963-5c8e-e063-6394a90a6527 | 2025-12-30 | Warnings | 6DC9Q167V3 |
| Quality Choice Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Chain Drug Marketing Assoc., Inc. | 0cd1b36a-a07a-a1db-e063-6294a90a5994 | 2025-12-30 | Warnings | 6DC9Q167V3 |
| Quality Choice Lubricant Eye Drops Long Lasting | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Chain Drug Marketing Assoc., Inc. | 0cd91c45-88a2-f88c-e063-6294a90ad127 | 2025-12-30 | Warnings | 6DC9Q167V3 |
| Quality Choice Eye Wash | WATER | Chain Drug Marketing Assoc., Inc. | 1fb8a109-351b-7039-e063-6394a90a7311 | 2025-12-30 | Warnings | 059QF0KO0R |
| Rite Aid Eye Wash | PURIFIED WATER | Rite Aid | 28a18e04-d735-a511-e063-6394a90af6bb | 2025-12-30 | Warnings | 059QF0KO0R |
| Archies Dry Eye Relief | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Archie's Remedies | 07da099b-6b7f-984d-e063-6294a90a12ac | 2025-12-30 | Warnings | 6DC9Q167V3 |
| OCUFRESH | WATER | Optics Laboratory Inc. | b8e477a9-66b9-496b-92fb-3d4bbd7b36b5 | 2025-12-29 | Warnings | 059QF0KO0R |
| Kollourion Eyesalve Eyewash | PURIFIED WATER 98.3% | Miracle Eye Pharmaceuticals | b56d2ab9-169b-b490-e053-2a95a90a80b3 | 2025-12-28 | Warnings | 059QF0KO0R |
| Walgreens Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4538-2061-e063-6394a90a6e73 | 2025-12-19 | Warnings | 6DC9Q167V3 |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| OneDrop | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 3cb9857f-529b-ad6c-e063-6294a90aa418 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.